Know Cancer

or
forgot password

Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer


N/A
N/A
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer


Genetic: It is a prospective study during two years with three years for follow-up. No
control group is recruited.


Inclusion Criteria:



- Patients with resectable non-small cell lung cancer (stage I to IIIA), with a
complete resection of the tumor and paired lymph nodes.

- Informed consent is required.

Exclusion Criteria:

- Another cancer

- Chemotherapy before surgical treatment

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Principal Investigator

Michèle BEAU-FALLER, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre

Authority:

France: Ministry of Health

Study ID:

3207

NCT ID:

NCT00213733

Start Date:

June 2004

Completion Date:

August 2011

Related Keywords:

  • Lung Cancer
  • Lung cancer patients
  • non-small cell lung cancer
  • molecular marker
  • lymph node completed resected
  • Lung cancer samples and paired lymph node resected
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location